Virotherapy: cancer gene therapy at last? [version 1; referees: 2 approved]

by Alan E. Bilsland, Pavlina Spiliopoulou, T. R. Jeffry Evans
Published 2016-08-01

Properties of a Telomerase-Specific Cre/Lox Switch for Transcriptionally Targeted Cancer Gene Therapy

by Alan E. Bilsland, Aileen Fletcher-Monaghan, W. Nicol Keith
Published 2005-11-01

Mathematical model of a telomerase transcriptional regulatory network developed by cell-based screening: analysis of inhibitor effects and telomerase expression mechanisms.

by Alan E Bilsland, Katrina Stevenson, Yu Liu, Stacey Hoare, Claire J Cairney, Jon Roffey, W Nicol Keith
Published 2014-02-01

A Novel Pyrazolopyrimidine Ligand of Human PGK1 and Stress Sensor DJ1 Modulates the Shelterin Complex and Telomere Length Regulation

by Alan E. Bilsland, Yu Liu, Andrew Turnbull, David Sumpton, Katrina Stevenson, Claire J. Cairney, Susan M. Boyd, Jon Roffey, David Jenkinson, W. Nicol Keith
Published 2019-09-01

Dynamic telomerase gene suppression via network effects of GSK3 inhibition.

by Alan E Bilsland, Stacey Hoare, Katrina Stevenson, Jane Plumb, Natividad Gomez-Roman, Claire Cairney, Sharon Burns, Kyle Lafferty-Whyte, Jon Roffey, Tim Hammonds, W Nicol Keith
Published 2009-07-01

Identification of a Selective G1-Phase Benzimidazolone Inhibitor by a Senescence-Targeted Virtual Screen Using Artificial Neural Networks

by Alan E. Bilsland, Angelo Pugliese, Yu Liu, John Revie, Sharon Burns, Carol McCormick, Claire J. Cairney, Justin Bower, Martin Drysdale, Masashi Narita, Mahito Sadaie, W. Nicol Keith
Published 2015-09-01

A 'synthetic-sickness' screen for senescence re-engagement targets in mutant cancer backgrounds.

by Claire J Cairney, Lauren S Godwin, Alan E Bilsland, Sharon Burns, Katrina H Stevenson, Lynn McGarry, John Revie, Jon D Moore, Ceri M Wiggins, Rebecca S Collinson, Clare Mudd, Elpida Tsonou, Mahito Sadaie, Dorothy C Bennett, Masashi Narita, Christopher J Torrance, W Nicol Keith
Published 2017-08-01